◆英語タイトル：VistaGen Therapeutics Inc (VTGN) - Financial and Strategic SWOT Analysis Review
◆産業分野：Pharmaceuticals and Healthcare
VistaGen Therapeutics Inc (VistaGen) is a clinical stage biopharmaceutical company that develops new generation medicines for depression and neuropsychiatric disorders. The company’s pipeline product, AV-101, currently under Phase 2 clinical development, is an oral N-methyl-D-aspartate receptor glycine B intended to treat major depressive disorder. It conducts research on their human pluripotent stem cell platform to predict toxic chemicals in heart. The company conducts clinical trials of its product in treatment of chronic neuropathic pain, epilepsy, huntington’s disease and parkinson’s disease. It partners with other healthcare industries for researching and assessing the drug effects on cardiac risk. VistaGen is headquartered in South San Francisco, California, the US.
VistaGen Therapeutics Inc Key Recent Developments
Mar 16,2021: VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March
Feb 18,2021: VistaGen Therapeutics Inc. (NASDAQ: VTGN) Committed to Developing New Generation of Medicines with Potential to Treat Rising Mental Health Challenges from Depression
Feb 11,2021: VistaGen Therapeutics Reports Fiscal 2021 Third Quarter Financial Results and Provides Update on Expected Clinical Studies in Calendar 2021
Dec 01,2020: VistaGen Therapeutics expands R&D team with appointment of Louis Monti, M.D., Ph.D., pioneer in the development of neuroactive steroids known as pherines as potential treatments for anxiety and depression disorders, as vice president, translational medicine
Nov 30,2020: VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Positive Preclinical Data for Potential Anxiety Treatment
This comprehensive SWOT profile of VistaGen Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of VistaGen Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
VistaGen Therapeutics Inc – Key Information
VistaGen Therapeutics Inc – Overview
VistaGen Therapeutics Inc – Key Employees
VistaGen Therapeutics Inc – Key Employee Biographies
VistaGen Therapeutics Inc – Key Operational Heads
VistaGen Therapeutics Inc – Major Products and Services
VistaGen Therapeutics Inc – History
VistaGen Therapeutics Inc – Company Statement
VistaGen Therapeutics Inc – Locations And Subsidiaries
VistaGen Therapeutics Inc
Other Locations & Subsidiaries
Section 2 – Company Analysis
VistaGen Therapeutics Inc – Business Description
VistaGen Therapeutics Inc – Corporate Strategy
VistaGen Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
VistaGen Therapeutics Inc – Strengths
VistaGen Therapeutics Inc – Weaknesses
VistaGen Therapeutics Inc – Opportunities
VistaGen Therapeutics Inc – Threats
VistaGen Therapeutics Inc – Key Competitors
Section 3 – Company Financial Performance Charts
VistaGen Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
VistaGen Therapeutics Inc, Key Information
VistaGen Therapeutics Inc, Key Ratios
VistaGen Therapeutics Inc, Share Data
VistaGen Therapeutics Inc, Major Products and Services
VistaGen Therapeutics Inc, History
VistaGen Therapeutics Inc, Key Employees
VistaGen Therapeutics Inc, Key Employee Biographies
VistaGen Therapeutics Inc, Key Operational Heads
VistaGen Therapeutics Inc, Other Locations
VistaGen Therapeutics Inc, Subsidiaries
VistaGen Therapeutics Inc, Key Competitors
VistaGen Therapeutics Inc, SWOT Analysis
VistaGen Therapeutics Inc, Ratios based on current share price
VistaGen Therapeutics Inc, Annual Ratios
VistaGen Therapeutics Inc, Interim Ratios
Capital Market Ratios
| ★海外企業調査レポート[VistaGen Therapeutics Inc (VTGN)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら